Concepedia

Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamide

Paul J. Hesketh, David R. Gandara, Ann M. Hesketh, Anna Facada, Edith A. Perez, Lauri M. Webber, Lorene A. Martin, Michael B. Cramer, William F. Hahne

Supportive Care in Cancer · 1996 · 33 citations · 12 references

DOI

Concepts

References

12

Serotonin Antagonists: A New Class of Antiemetic Agents

Paul J. Hesketh, David R. Gandara · JNCI Journal of the National Cancer Institute · 1991 · 163 citations

, , +13

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

Mark G. Kris, Richard J. Gralla, Rebecca A. Clark et al. · Cancer · 1987 · 150 citations · Full text

, , +15

Efficacy of Oral Ondansetron in the Prevention of Emesis in Outpatients Receiving Cyclophosphamide-based Chemotherapy

Thomas Beck · Annals of Internal Medicine · 1993 · 88 citations

, , +15

Pharmacological properties of dolasetron, a potent and selective antagonist at 5‐HT<sub>3</sub> receptors

Robert C. Miller, Martin Galvan, Maurice W. Gittos et al. · Drug Development Research · 1993 · 81 citations

, , +12

Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin.

Mark G. Kris, Steven M. Grunberg, R J Gralla et al. · Journal of Clinical Oncology · 1994 · 78 citations

, , +17